Quantitative analysis of urinary stone composition with micro-Raman spectroscopy

Urolithiasis is a common, disturbing disease with high recurrent rate (60% in five years). Accurate identification of urinary stone composition is important for treatment and prevention purpose. Our previous studies have demonstrated that micro-Raman spectroscopy (MRS)-based approach successfully detects the composition of tiny stone powders after minimal invasive urological surgery. But quantitative analysis of urinary stones was not established yet. In this study, human urinary stone mixed with two compositions of COM, HAP, COD, and uric acid, were analyzed quantitatively by using a 632.98 nm Raman spectrometric system. This quantitative analysis was based on the construction of calibration curves of known mixtures of synthetically prepared pure COM, HAP, COD and uric acid. First, the various concentration (mole fraction) ratio of binary mixtures including COM and HAP, COM and COD, or COM and uric acid, were produced. Second, the intensities of the characteristic bands at 1462cm -1(IRCOM), 1477cm-1(IRCOD), 961cm-1(IRHAP) and 1402cm-1(IRuric acid), for COD, COM, HAP and uric acid were used respectively for intensity calculation. Various binary mixtures of known concentration ratio were recorded as the basis for the quantitative analysis. The ratios of the relative intensities of the Raman bands corresponding to binary mixtures of known composition on the inverse of the COM concentration yielded a linear dependence. Third, urinary stone fragments collected from patients after management were analyzed with the use of the calibration curve and the quantitative analysis of unknown samples was made by the interpolation analysis. We successfully developed a MRS-based quantitative analytical method for measuring two composition.

[1]  H. Tiselius.  Recurrence Prevention in Patients with Urinary Tract Stone Disease , 2004, TheScientificWorldJournal.

[2]  A Hesse,et al.  Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. , 2003, European urology.

[3]  G. Curhan,et al.  Time trends in reported prevalence of kidney stones in the United States: 1976-1994. , 2003, Kidney international.

[4]  Daehee Kang,et al.  Prevalence and epidemiologic characteristics of urolithiasis in Seoul, Korea. , 2002, Urology.

[5]  Pedro Carmona,et al.  Infrared and Raman spectroscopy of urinary calculi: A review , 1997 .

[6]  C. Kontoyannis,et al.  Raman spectroscopy: A tool for the quantitative analysis of mineral components of solid mixtures. The case of calcium oxalate monohydrate and hydroxyapatite , 1997 .

[7]  M. Straub.  [What kind of stone prevention for whom? Risk-adjusted metaphylaxis following urinary stone disease]. , 2006, Der Urologe. Ausg. A.

[8]  Sangtae Park.  Medical management of urinary stone disease , 2007, Expert opinion on pharmacotherapy.

[9]  Beverley Adams-Huet,et al.  Predictive value of kidney stone composition in the detection of metabolic abnormalities. , 2003, The American journal of medicine.

[10]  Luke S. Chang,et al.  Epidemiological Studies on the Prevalence of Upper Urinary Calculi in Taiwan , 2002, Urologia Internationalis.

[11]  O. Karatas,et al.  Prognostic Factors Effecting on Recurrence of Urinary Stone Disease: A Multivariate Analysis of Everyday Patient Parameters , 2005, International Urology and Nephrology.

[12]  C. Kontoyannis,et al.  Use of Raman Spectroscopy for the Quantitative Analysis of Calcium Oxalate Hydrates: Application for the Analysis of Urinary Stones , 1997 .